MARKET

CORV

Correvio Pharma Corp
CORV
NASDAQ
Delisted
P/E
P/S
P/B
MARKET CAP
-0.5284
0.5694
-27.8079
27,793,595.44
News
Financial
Releases
Corp Actions
Analysis
Profile
Correvio Obtains Final Order for Plan of Arrangement
CNW Group · 05/21 21:01
Correvio Pharma Reports Obtained Final Order For Plan Of Arrangement For $76M
Benzinga · 05/21 20:03
Merger Arbitrage Mondays - A Large Number Of Rumored Deals But No Cigar
Seeking Alpha - Article · 05/18 13:35
Correvio Announces Results from Annual General and Special Meeting of Securityholders
CNW Group · 05/15 22:55
Will Correvio Pharma (CORV) Report Negative Q1 Earnings? What You Should Know
Correvio (CORV) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks · 05/06 16:30
Leading Independent Proxy Advisory Firm Glass Lewis Recommends That Correvio Shareholders Vote for the Arrangement With ADVANZ PHARMA
PR Newswire · 05/06 13:00
Leading Independent Proxy Advisory Firm ISS Recommends That Correvio Shareholders Vote for the Arrangement with ADVANZ PHARMA
PR Newswire · 05/01 13:00
Correvio Reports ISS Recommends Shareholders Vote For Deal With ADVANZ PHARMA
Benzinga · 05/01 12:08
More
Forecast
EPSBVPSCFPS
Actual (USD)
Estimate (USD)
Income StatementMore
Net IncomeTotal RevenueOperating Income
Net Income (USD)
YoY (%)
Balance SheetMore
Total Assets (USD)
Total Liabilities (USD)
Debt to Asset (%)
Cash FlowMore
OperatingInvestingFinancing
Operating (USD)
YoY (%)
Learn about the latest financial forecast of CORV. Analyze the recent business situations of Correvio Pharma Corp through EPS, BVPS, FPS, and other data. This information may help you make smarter investment decisions.
Analyst Rating

Based on 2 analysts

Hold

Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.

Analyst Price Target
The average CORV stock price target is 1.085 with a high estimate of 1.750 and a low estimate of 0.4200.
EPS
  • Performance
  • Asset Allocation
  • Dividend History
No Data
Industry
Pharmaceuticals
-0.15%
Pharmaceuticals & Medical Research
-0.45%
Key Executives
Chairman/Independent Director
W. James O'Shea
President/Chief Financial Officer/IR Contact Officer
Justin Renz
Chief Executive Officer/Director
Mark Corrigan
Chief Operating Officer
Sheila Grant
General Counsel
David McMasters
Other
David Dean
Other
Hugues Sachot
Director
William Hunter
Independent Director
Vanda De Cian
Independent Director
Richard Glickman
Independent Director
Vanda Cian
Independent Director
Robert Meyer
Independent Director
Arthur Willms
  • Dividends
  • Splits
  • Insider Activity
No Data
Access Level 2 Advance
Nasdaq TotalView
for Free
Get Now
Hot Stocks
Symbol
Price
%Change

Webull offers kinds of Correvio Pharma Corp stock information, including NASDAQ:CORV real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, CORV stock news, and many more online research tools to help you make informed decisions.

You can practice and explore trading CORV stock methods without spending real money on the virtual paper trading platform.